Your browser doesn't support javascript.
loading
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
Berg, David D; Wiviott, Stephen D; Scirica, Benjamin M; Gurmu, Yared; Mosenzon, Ofri; Murphy, Sabina A; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Johanson, Per; Johansson, Peter A; Langkilde, Anna Maria; Raz, Itamar; Braunwald, Eugene; Sabatine, Marc S.
Afiliación
  • Berg DD; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.D.B., S.D.W., B.M.S., Y.G., S.A.M., D.L.B., E.B., M.S.S.).
  • Wiviott SD; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.D.B., S.D.W., B.M.S., Y.G., S.A.M., D.L.B., E.B., M.S.S.).
  • Scirica BM; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.D.B., S.D.W., B.M.S., Y.G., S.A.M., D.L.B., E.B., M.S.S.).
  • Gurmu Y; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.D.B., S.D.W., B.M.S., Y.G., S.A.M., D.L.B., E.B., M.S.S.).
  • Mosenzon O; Hadassah Hebrew University Hospital, Jerusalem, Israel (O.M., I.R.).
  • Murphy SA; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.D.B., S.D.W., B.M.S., Y.G., S.A.M., D.L.B., E.B., M.S.S.).
  • Bhatt DL; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.D.B., S.D.W., B.M.S., Y.G., S.A.M., D.L.B., E.B., M.S.S.).
  • Leiter LA; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Canada (L.A.L.).
  • McGuire DK; University of Texas Southwestern Medical Center, Dallas (D.K.M.).
  • Wilding JPH; University of Liverpool, United Kingdom (J.P.H.W.).
  • Johanson P; AstraZeneca, Gothenburg, Sweden (P.J., P.A.J., A.M.L.).
  • Johansson PA; AstraZeneca, Gothenburg, Sweden (P.J., P.A.J., A.M.L.).
  • Langkilde AM; AstraZeneca, Gothenburg, Sweden (P.J., P.A.J., A.M.L.).
  • Raz I; Hadassah Hebrew University Hospital, Jerusalem, Israel (O.M., I.R.).
  • Braunwald E; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.D.B., S.D.W., B.M.S., Y.G., S.A.M., D.L.B., E.B., M.S.S.).
  • Sabatine MS; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.D.B., S.D.W., B.M.S., Y.G., S.A.M., D.L.B., E.B., M.S.S.).
Circulation ; 140(19): 1569-1577, 2019 11 05.
Article en En | MEDLINE | ID: mdl-31474116
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Técnicas de Apoyo para la Decisión / Diabetes Mellitus Tipo 2 / Cardiomiopatías Diabéticas / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Circulation Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Técnicas de Apoyo para la Decisión / Diabetes Mellitus Tipo 2 / Cardiomiopatías Diabéticas / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Circulation Año: 2019 Tipo del documento: Article